PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 103 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,410 | -3.2% | 50,414 | -0.8% | 1.46% | -8.3% |
| Q4 2022 | $5,590 | -99.8% | 50,814 | -0.5% | 1.59% | +75.9% |
| Q3 2022 | $3,012,000 | +113.2% | 51,047 | +2.0% | 0.90% | +126.1% |
| Q2 2022 | $1,413,000 | +34.3% | 50,047 | +79.7% | 0.40% | +50.0% |
| Q1 2022 | $1,052,000 | -4.5% | 27,857 | 0.0% | 0.27% | -4.7% |
| Q4 2021 | $1,101,000 | – | 27,857 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $198,329,936 | 93.93% |
| CHI Advisors LLC | 934,135 | $100,251,367 | 26.61% |
| Cormorant Asset Management, LP | 1,655,000 | $177,615 | 11.70% |
| Boxer Capital, LLC | 1,897,500 | $203,640 | 10.00% |
| RTW INVESTMENTS, LP | 3,272,104 | $351,162,201 | 7.31% |
| Decheng Capital Management III (Cayman), LLC | 150,000 | $16,098,000 | 6.50% |
| Waypoint Capital Advisors, LLC | 154,466 | $16,577,292 | 5.40% |
| Affinity Asset Advisors, LLC | 150,000 | $16,098,000 | 5.31% |
| Perceptive Advisors | 1,272,694 | $136,585,520 | 4.03% |
| Ikarian Capital, LLC | 125,926 | $13,514,378 | 3.07% |